Skip to main content

SYSTEMATIC REVIEW article

Front. Neurol., 26 September 2022
Sec. Neurorehabilitation
This article is part of the Research Topic Complementary Therapies for Neurological Disorders: From Bench to Clinical Practices View all 14 articles

Bibliometric review of 1992–2022 publications on acupuncture for cognitive impairment

\nRunjin Zhou&#x;Runjin Zhou1Lu Xiao*&#x;Lu Xiao2*Wei XiaoWei Xiao2Yanfei YiYanfei Yi2Huanhuan WenHuanhuan Wen2Hongda WangHongda Wang2
  • 1Medical College of Acupuncture-Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China
  • 2Ganzhou Cancer Hospital, Ganzhou, China

Objective: To explore the development context, research hotspots, and frontiers of acupuncture therapy for cognitive impairment (CI) from 1992 to 2022 by visualization analysis.

Methods: Articles about acupuncture therapy for cognitive impairment were retrieved from the Web of Science Core Collection (WoSCC) until 1 March 2022. Basic information was collected by Excel 2007, and VOSviewer 1.6.17 was used to analyze the co-occurrence of countries, institutes, and authors. Co-citation maps of authors and references were analyzed by CiteSpace V.5.8.R3. In addition, CiteSpace was used to analyze keyword clusters and forecast research frontiers.

Results: A total of 279 articles were retrieved, including articles from 19 countries, 334 research institutes, and 101 academic journals. The most published country and institutes were the People's Republic of China (217) and the Fujian University of Traditional Chinese Medicine (40). Ronald C Petersen owned the highest co-citations (56). Keywords and co-cited references cluster showed the main research directions in this area, including “ischemic stroke,” “cerebral ischemia/reperfusion,” “mild cognitive impairment,” “Alzheimer's disease,” “vascular dementia,” “vascular cognitive impairment with no dementia,” “multi-infarct dementia,” “synaptic injury,” “functional MRI,” “glucose metabolism,” “NMDA,” “nuclear factor-kappa b pathway,” “neurotrophic factor,” “matrix metalloproteinase-2 (MMP-2),” “tumor necrosis factor-alpha,” “Bax,” “Caspase-3,” and “Noxa”. Trending keywords may indicate frontier topics, such as “randomized controlled trial,” “rat model,” and “meta-analysis.”

Conclusion: This research provides valuable information for the study of acupuncture. Diseases focus on mild cognitive impairment (MCI), Alzheimer's disease (AD), and vascular dementia (VaD). Tauopathies with hyperphosphorylation of Tau protein as the main lesions also need to be paid attention to. The development of functional magnetic resonance imaging (fMRI) will better explain the therapeutic effect of acupuncture treatment. The effect of acupuncture on a single point is more convincing, and acupuncture on Baihui (GV20) may be needed in the future. Finally, the implementation of high-quality multicenter randomized controlled trials (RCTs) requires increased collaboration among experts from multiple fields and countries.

Introduction

Cognitive function refers to all kinds of conscious mental activities that human beings always have in the state of awakening, such as simple determination, perception, understanding, and judgment of themselves and the environment to complete complex mathematical calculations (1, 2). Cognitive impairment (CI) is a pathological process in which learning, memory, and thinking judgment related to the brain's advanced intelligent processing are abnormal, resulting in learning and memory disorders, accompanied by aphasia, apraxia, agnosia, and other changes, from mild cognitive impairment (MCI) to dementia (1, 2). MCI is a symptomatic diagnosis in which a patient has a memory or cognitive dysfunction that does not significantly affect daily functioning and does not reach the level of dementia (3). It is an intermediate state between normal aging and dementia, and the prevalence of MCI in adults 65 years and older ranges from 3 to 20%, with more than half progressing to dementia within 5 years (4, 5). Dementia is an acquired intelligence impairment syndrome with cognitive impairment as its core symptom. Cognitive impairment involves memory, learning, orientation, understanding, judgment, computation, language, visual space, and other functions (6). At present, the international diagnosis of dementia includes the American Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (1) and the International Classification of Diseases, 11th Revision (ICD-11) (2). According to the lesion location, it can be divided into cortical dementia (Alzheimer's disease and frontotemporal degeneration), subcortical dementia (vascular dementia [VaD]), mixed cortical and subcortical dementia (multiple infarct dementia, infectious dementia, poisoning, and metabolic encephalopathy), and other dementias (post-traumatic brain injury dementia, etc.).

Of these, Alzheimer's disease (AD) has the highest incidence, and the number of patients in the world has reached 50 million, which is expected to increase to 152 million in 2050, according to the World Alzheimer Report 2019. Patients with AD have decreased the ability of daily living and abnormal mental behavior, posing a significant burden on family caregivers and society (7). It is necessary to find an effective, safe, and inexpensive treatment for older patients. In 2019, the 72nd World Health Assembly passed the ICD-11, which includes traditional Chinese medicine for the first time. Acupuncture is widely used in Asia as one of the non-pharmacological interventions of traditional Chinese medicine. The results of case-control trials based on functional magnetic resonance imaging (fMRI) showed that acupuncture at the Taixi (KI3) acupoint could activate neurons in the cerebral cortex related to cognition, providing imaging evidence support for clinical treatment of CI (8, 9). Randomized controlled trials (RCTs) suggested that acupuncture could improve cognitive function in patients with mild to moderate cognitive impairment (10, 11). In addition, animal experiments are trying to clarify the mechanism of acupuncture (12, 13).

Acupuncture is a technique that has been practiced for thousands of years, and its description can be traced back to a book called The Huangdi's Internal Classic, dating from the Han Dynasty (14). During the operation, Deqi is generated by needles into specific acupoints of the human body, so as to achieve the effect of treating diseases (15).

In recent years, more and more research articles on acupuncture have been published. Currently, the reporting quality of RCTs of acupuncture for MCI is moderate to low (16, 17). Most clinical trials did not mention allocation concealment and blinding, nor did they strictly followed the Consolidated Standards for Reporting of Trials (CONSORT) statement and Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA). There is currently a lack of systematic review of trends in this field. Bibliometric visualization analysis is a quantitative analysis method that combines mathematics and statistical methods. It can intuitively highlight the quantitative characteristics of research articles in a certain field and help researchers grasp the development characteristics of the field over time (18). Therefore, this study adopts bibliometric analysis to conduct a systematic review of the application of acupuncture therapy to CI research, aiming to understand the cooperative network, and evaluate the research trends and frontiers.

Materials and methods

Data source and search strategy

Article retrieval was conducted on the Science Citation Index-Expanded (SCI-E) of the Web of Science Core Collection (WoSCC) on 20 March 2022. WoSCC is a relatively comprehensive citation database, and considering that it has the highest applicability with CiteSpace software, so WoSCC was chosen as the preferred retrieval database in this study. The terms “Acupuncture” and “Cognitive Impairment” were used in the MeSH (https://www.ncbi.nlm.nih.gov/mesh) search. The data retrieval strategy is as follows: TS = (Acupuncture OR Pharmacopuncture OR Acupressure OR Acupuncture Therapy OR Acupuncture Point* OR acupunct* OR needl* OR Electroacupuncture OR Ear Acupuncture OR Auricular* OR meridian* OR acupoint*) AND TS= (Cognitive Dysfunction OR Cognitive Impairment OR Neurocognitive Disorder OR Cognitive Decline OR Mild cognitive impairment OR Alzheimer's disease OR dementia OR Vascular dementia). The time span: 01-01-1992 to 01-03-2022.

Inclusion/exclusion criteria

Inclusion criteria

The article type is mainly articles in English, and the research type includes randomized controlled trials (RCTs), retrospective studies, case reports, and animal experiments. The main study population is patients with CI, and the intervention is acupuncture therapy.

Exclusion criteria

Secondary article, such as reviews and meta-analyses, were excluded. In addition, book chapters, letters, editorial material, and meeting abstracts were excluded. At the same time, by reading the abstracts and full texts, researchers should also exclude articles that only briefly mention acupuncture therapy without involving specific therapeutic effects and mechanisms.

Data collection

Raw data from WoSCC were downloaded and verified by two members (LX and RJZ), respectively. The flow chart of research inclusion is shown in Figure 1. The data were then imported into CiteSpace V.5.8.R3 (Drexel University, Philadelphia, PA, USA) and VOSviewer 1.6.17 (Leiden University, Van Eck NJ). The information generated by the software is imported into Excel 2007 (Redmond, WA, USA).

FIGURE 1
www.frontiersin.org

Figure 1. Articles screening flow chart. Two researchers independently evaluated 669 articles according to the inclusion and exclusion criteria and finally obtained 279 qualified articles.

Statistical methods

The WoSCC database was used to analyze the characteristics of the article, such as the number of annual publications and citations, journal sources, research areas, H-index, and impact factor. VOSviewer is a bibliometric analysis software jointly developed by Nees Jan van Eck and Ludo Waltman for mapping scientific knowledge (19). It was used to analyze the co-occurrence of countries/regions, institutes, and authors (which were based on the first author). There were three types of mapping generated: Network Visualization, Overlay Visualization, and Density Visualization. For the Density Visualization, darker yellow indicated more important research. CiteSpace is a tool for visualizing and analyzing trends and patterns in scientific articles (20, 21). It was used for reference/author co-citation analysis, we define that the nodes in the co-citation knowledge graph represent different documents, and the size of the node is proportional to the number of references cited in a specific period. Similarly, a connection between nodes indicates the degree of relationship, the thicker the line, the stronger the connection. Co-occurrence of keywords was analyzed by CiteSpace. We analyzed the characteristics related to keyword clusters, in which the purple reference ring represented the research's high mediating centrality, which played a role in connecting various documents, and the orange represented the newly emerging research (22). This will make it more intuitive to observe the trend of various research hotspots over time.

Results

Annual publications and citations

In total, 279 articles were included from 1992 (n = 1) to 2021 (n = 37), the citations of these articles also increased rapidly from 2003 (n = 1) to 2021 (n =781), with a total of 3,869 citations (Figure 2).

FIGURE 2
www.frontiersin.org

Figure 2. Sum of publications and citations. The number of publications and citations from 1992 to 2021 is described by a line chart, where blue represent the number of publications and yellow represent the number of citations (× 0.1).

Research areas analysis

A total of 33 research areas were represented. Neurosciences and Neurology (n = 101), Integrative Complementary Medicine (n = 71), and Research Experimental Medicine (n = 44) occupied the main position. Figure 3 shows the top 10 research areas in acupuncture therapy for cognitive impairment.

FIGURE 3
www.frontiersin.org

Figure 3. The top 10 research areas about acupuncture therapy for cognitive impairment (CI). The bar chart is used to describe the top 10 research areas. Each specific research area is listed on the Y-axis, and the corresponding percentage on the X-axis has its proportion.

Distribution of journals and highly cited articles

A total of 101 academic journals have published publications on acupuncture therapy for cognitive impairment. Table 1 lists the top 10 journals with a total of 137 articles. Evidence-based Complementary and Alternative Medicine published the most articles (n = 23), followed by Trials (n = 18) and Neural Regeneration Research (n = 14). Figure 4 displayed the dual-map overlay of journals (23), the left and right sides corresponded to the citation map and the cited journal map, respectively. These labels represented the disciplines covered by the journal. Lines on the map start from the left and end on the right, representing citation links. There were three citation paths: molecular/biology/immunology journals represented by the yellow path, medicine/medical/clinical journals represented by the green path, and neurology/sports/ophthalmology journals represented by the pink path are cited in molecular/biology/genetics areas. Table 2 shows the 10 most frequently cited articles.

TABLE 1
www.frontiersin.org

Table 1. The top 10 journals that published articles.

FIGURE 4
www.frontiersin.org

Figure 4. The dual-map overlay of journals. The left side correspond to the citation map and the right side represent the cited journal map. Molecular/biology/immunology journals represented by the yellow path, medicine/ medical/ clinical journals represented by the green path, and neurology/sports/ophthalmology journals represented by the pink path are cited in molecular/biology/genetics areas.

TABLE 2
www.frontiersin.org

Table 2. Top 10 most cited articles.

Distribution of countries and institutes

A total of 19 countries/regions have published research publications on acupuncture therapy for cognitive impairment, and extensive cooperation between countries/regions has been observed (Figure 5). Table 3 lists the top 10 countries/regions in the number of publications, of which China is the most, followed by South Korea, the United States, and England. At present, the research on acupuncture treatment of CI is mainly concentrated in China and South Korea. With the increase of international exchanges in recent years, the United States and England are gradually increasing their participation in research, and the multi-country cooperation model is gradually being carried out.

FIGURE 5
www.frontiersin.org

Figure 5. The network map of countries/regions, institutes, and active authors. (A) The Network Visualization map of countries/regions, (B) the Overlay Visualization map of countries/regions, and (C) the Density Visualization map of countries/regions. (D) The Network Visualization map of institutes, (E) the Overlay Visualization map of institutes, and (F) the Density Visualization map of institutes. (G) The Network Visualization map of active authors, (H) the Overlay Visualization map of active authors, and (I) the Density Visualization map of active authors.

TABLE 3
www.frontiersin.org

Table 3. Top 10 countries/region and institutions in the number of publications.

In total, 334 institutes participated in acupuncture research (Figure 5). Table 3 lists the top 10 institutes in terms of publications. It should be noted that we have merged different names of the same institutes, such as Fujian University of TCM merged into Fujian University of Traditional Chinese Medicine, Guangzhou University of Traditional Chinese Medicine merged into Guangzhou University of Chinese Medicine. Statistics showed that the top 10 institutes account for 73.48% of total publications, among which Fujian University of Traditional Chinese Medicine has the largest publications, followed by Capital Medical University and Beijing University of Chinese Medicine.

Analysis of citations and H-index

China ranked first among the top five productive countries in terms of the total number of citations and H-index, followed by South Korea, the United States, England, and Italy (Figure 6). All countries have not contributed to the ESI top articles. High-impact research achievements are still needed in this field.

FIGURE 6
www.frontiersin.org

Figure 6. The distribution of citation (× 0.01), number of citations per article, and H-index in the top 5 countries. According to the number of citations and H-index, the histogram intuitively shows the top 5 countries, among which Chinese scholars have done the most research in this field and have the highest influence.

Analysis of authors

Over 1,210 authors contributed to acupuncture research. The co-occurrence map of authors is shown in Figure 5. Table 4 lists the top 10 authors in the number of publications. Li-Dian Chen and Cun-Zhi Liu (26 publications) were both ranked first, followed by Jing Tao (25 publications) and Jia Huang (19 publications).

TABLE 4
www.frontiersin.org

Table 4. The top 10 authors, co-cited authors, and keywords.

The co-citation of authors was analyzed by CiteSpace (Figure 7A). Among the top 10 co-cited authors (Table 4), Ronald C Petersen (56 co-citations) ranked first, followed by Zhi-Qun Wang (53 co-citations), and Jian-Chun Yu (46 co-citations). The top 17 authors with the strongest citation bursts are listed in Figure 8A, and the beginning to the end of each burst interval is indicated by a red line. Jing Zhou (strength 4.38, 2017–2022), Meng Zhang (strength 4.43, 2019–2022), Min Deng (strength 4.40, 2019–2022), Nasreddine ZS (strength 4.38, 2017–2022), Yang-Juan Jia (strength 4.08, 2019–2022), and Jing Jiang (strength 4.08, 2019–2022) have been cited in recent 3 years, indicating that the authors have been active in this field in recent years. New research has been published in the study of cognitive impairment.

FIGURE 7
www.frontiersin.org

Figure 7. The co-citation map of authors and references. (A) The co-citation map of authors and (B) the co-citation map of authors references.

FIGURE 8
www.frontiersin.org

Figure 8. The co-cited authors, co-cited references, and keyword with the strongest citation bursts. (A) The co-cited authors with the strongest citation bursts, (B) the co-cited references with the strongest citation bursts, and (C) the keyword with the strongest citation bursts. Among them, the co-cited authors, co-cited references, and keywords in the red box are the most obvious in the past 3 years, which may be the latest research hotspots.

Analysis of co-cited references

We used CiteSpace to analyze the co-citation of references (Figure 7B). Table 5 lists the top 10 co-cited references. The co-cited reference clusters are shown in Figure 9A. The network contained 592 nodes and 1,535 links. The Modularity Q was 0.8741 (>0.5), meaning that the clusters of networks were reasonable, and the Mean Silhouette S was 0.9285 (>0.5), indicating that the homogeneity of clusters were acceptable (20). In this network, more important clustering labels were listed in 20 clusters: #0 vascular dementia, #1 ischemic stroke, #2 NMDA, #3 nerve regeneration, #4 mild cognitive impairment, #5 Alzheimer's disease, #6 nuclear factor-kappa b pathway, #7 tumor necrosis factor-alpha, #8 synaptic injury, #9 Bax, #11 energy metabolism, #12 multi-infarct dementia, #13 vascular cognitive impairment with no dementia, #16 waiguan (SJ5), and #19 Caspase-3. The top 13 co-cited references with the strongest citation bursts are listed in Figure 8B.

TABLE 5
www.frontiersin.org

Table 5. The top 10 co-cited references.

FIGURE 9
www.frontiersin.org

Figure 9. The co-cited reference and keyword clusters map for publications. (A) The co-cited reference clusters map for publications and (B) the keyword clusters map for publications. In clustering, the same elements would be aggregated together, each cluster existed independently, and the cluster label is a name for each cluster diagram.

Analysis of keywords

CiteSpace was used to analyze the co-occurrence of keywords (Figure 10). Table 4 lists the top 10 keywords. Co-cited keyword clusters network contained 375 nodes and 1,006 links. the Modularity Q was 0.7254, and the Mean Silhouette S was 0.9044 (>0.5) (Figure 9B). There were 16 clustering labels listed: #0 cerebral ischemia/reperfusion, #1 memory, #2 brain, #3 clinical trial, #4 randomized controlled trial, #5 vascular dementia, #6 traditional Chinese medicine, #7 rehacom training, #8 functional MRI, #9 cognitive deficits, #10 protein, #11 glucose metabolism, #12 neurotrophic factor, #13 dentate gyrus, #14 matrix metalloproteinase-2 (MMP-2), and #15 Noxa. The top 23 co-cited keywords with the strongest citation bursts are listed in Figure 8C. As shown in the figure, the part selected by the red square represents the highly cited keywords in recent years, which are mainly reflected in randomized controlled trials, meta-analysis, and the construction of animal models.

FIGURE 10
www.frontiersin.org

Figure 10. The co-occurrence map of keywords. CiteSpace was used to analyze the co-occurrence of keywords. The figure shows that the keywords, such as Alzheimer's disease (AD), acupuncture, electroacupuncture, brain, activation, and Baihui occupied the main position.

Discussion

General information

The number of publications and citations has shown a rapid upward trend every year, indicating that acupuncture therapy for MCI research is still attracting attention. Among the top 10 contributing countries, China and South Korea accounted for the largest proportion (87.10%). Research institutions are also represented by traditional Chinese medicine colleges, which reflects the high acceptance of acupuncture in Asia. In terms of the distribution of authors, Li-Dian Chen ranked first in 26 publications. According to Price's Law (24), the minimum number of publications for core authors is N = 0.749Mmax (Mmax is the publications of the most prolific authors), calculated at N ≈ 4. In terms of the number of articles published, 89 authors have published more than 4 articles, accounting for 7.36% (< 50%), indicating that the core author team in this research field has not yet been formed. At present, scholars who study acupuncture for CI are mainly concentrated in Asia and relatively few in Europe and the United States, which may have a certain relationship with the culture they come into contact with. It is necessary to popularize acupuncture and let more people know about it. At the same time, strengthening the cooperation and exchanges between scholars from various countries will help to further explore the effective mechanism of acupuncture treatment. Perhaps this will not only be limited to the study of improving cognitive function.

Research hotspots and frontiers

RCTs of acupuncture therapy for MCI

Earlier identification and intervention of mild cognitive impairment are necessary to delay the progression of the disease to dementia. The results of the meta-analysis based on RCTs suggested that acupuncture is effective in the treatment of patients with MCI and can improve their activity on a daily living scale, the mini-mental state examination (MMSE), and Montreal cognitive assessment scores (MoCA) (25). As mentioned in the preface, the lack of high-quality RCT articles is the main reason leading to the medium-low quality evidence of acupuncture treatment CI. There is still a need for standardized reports on acupuncture research.

Animal models focus on AD and VaD

Alzheimer's disease models involved in this study include the rapid aging models, transgenic models, and Aβ injection models. Senescence-Accelerated Mice include two strains, SAM-P and SAM-R (26, 27). SAM-P exhibits rapid aging, AD-specific Aβ aggregation, and hyperphosphorylation of Tau protein in pathology. SAM-P has 9 sub-strains, among which SAMP8 is an ideal animal model for aging-related learning and memory deficits that are similar to the clinical manifestations of patients with AD (28). SAMR1 mice retain normal aging characteristics and are often used as controls. The transgenic animal models involved in this study are amyloid precursor protein/Presenilin 1 (APP/PS1) mice and five familial mutations (5XFAD) mice. APPSwe/PS1 (B6C3-Tg (APPswe, PSEN1dE9) 85Dbo/J) double transgenic mice model. APPSwe is the Swedish mutation of the amyloid precursor protein, whereas PS1 is the mutant form of human presenilin 1 (29). 5XFAD mice overexpress human amyloid precursor protein (APP) and presenilin-1 (PS1) mutants, namely, the Swedish (K670 N and M671 L), Florida (I716V), and London (V717I) mutations in APP and the PS1 mutations M146 L and L286 V (30). The above two kinds of transgenic animals can specifically produce excessive APP, which affects the accumulation of Aβ, and finally forms senile plaques (SP). Aβ injection models are used to inject Aβ polypeptide fragments of different lengths into specific brain regions, such as Aβ1-40 (31) and Aβ1-42 (32). It is worth mentioning that all the animal studies on the acupuncture treatment of AD seem to be directed at the regulatory mechanism of Aβ. At present, there are few studies on tauopathies, which we believe can be further studied in the future.

For VaD models, the permanent, bilateral common carotid artery occlusion (2-VO) is most commonly used in this study (33). By ligating the common carotid artery, a chronic cerebral hypoperfusion state is created, thereby causing ischemia and hypoxia in brain tissue, especially the hippocampus and cortex. However, this modeling method has a high lethality rate, and the modified version of 2-VO can improve the survival rate.

Various putative mechanisms of acupuncture in the treatment of AD and VaD

The putative mechanism of acupuncture in the treatment of AD and VaD mainly focuses on the repair of neuroinflammation, regulating autophagy and apoptosis, and improving energy metabolism. Tables 6, 7 lists the different putative mechanisms of acupuncture for AD (3470) and VaD (7185). It is worth noting that Baihui (GV20, also called DU20) occupies the most acupuncture points, prompting its importance in acupoint selection. Furthermore, the selection of acupuncture points is based on the theory of Chinese medicine, and most of the points are not at least one. The final result makes it difficult to determine whether it is the effect of single point stimulation or superposition of combination. In the experimental grouping, in addition to setting up the sham group, the setting of a single acupoint or combination needs further consideration.

TABLE 6
www.frontiersin.org

Table 6. The putative mechanisms of acupuncture on different Alzheimer's disease animal models.

TABLE 7
www.frontiersin.org

Table 7. Mechanisms of acupuncture on different vascular dementia animal models.

Functional magnetic resonance imaging is one of the important tools to research cognitive function

Functional magnetic resonance imaging is a non-invasive neuroimaging method with a high spatial resolution to study brain function. Its method of detecting functional connectivity of various brain regions in resting or task states may objectively identify cognitive impairment. Acupuncture in the cognitive impairment group compared with healthy controls to observe whether cognitive-related brain areas (such as dentate gyrus, frontotemporal lobe, and frontal lobe) are activated (8688).

Limitations

This study also has some disadvantages: first, our study was conducted on 20 March 2022, and included all articles up to 01 March 2022, but since the WoSCC database is still open to relevant documents in 2022, this section is omitted. Second, since each published article was limited to 3–10 keywords, some core words in these articles were not included in the bibliometric analysis, so the analysis results may also be affected by incomplete keyword extraction. Finally, as the search was limited to journals indexed in the WoSCC database, some articles not included in the WOSCC database were left out. Other bibliometric studies have also reported these limitations (8991).

Conclusion

We analyzed the research progress of acupuncture in the treatment of CI through the visualization analysis, and this study shows the current achievements of acupuncture in the treatment of CI and the possible directions of further research in the future, which will be helpful for clinicians and researchers. The results suggest that diseases focus on MCI, AD, and VaD. Pathologically, the detection of Aβ and APP is the main concern. Tauopathies with hyperphosphorylation of Tau protein as the main lesions also need to be paid attention to. In addition, fMRI is one of the means to elucidate the mechanism of treatment. At the same time, the complexity of acupoint selection makes it difficult to explain the specific pathway mechanism of acupuncture treatment of diseases. We think it is necessary to select a single point, and we found that Baihui (GV20) is the most commonly used, so we suggest that researchers can further elaborate on the mechanism of treating CI with GV20 acupuncture. Finally, the implementation of high-quality multicenter randomized controlled trials requires increased collaboration among experts from multiple fields and countries.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author/s.

Author contributions

RZ and LX conceived and designed the experiments, authored, and reviewed drafts of the paper. RZ wrote the original draft. YY, RZ, WX, and LX analyzed the data. LX reviewed and edited the final draft. HWa, YY, RZ, LX, and WX performed the experiments and approved the final draft. HWa, YY, and WX prepared figures and/or tables. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2022.1006830/full#supplementary-material

References

1. Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. (2014) 10:634–42. doi: 10.1038/nrneurol.2014.181

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry. (2019) 18:3–19. doi: 10.1002/wps.20611

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. (2004) 256:183–94. doi: 10.1111/j.1365-2796.2004.01388.x

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. (2014) 312:2551–61. doi: 10.1001/jama.2014.13806

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet. (2006) 367:1262–70. doi: 10.1016/S0140-6736(06)68542-5

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Ritchie K, LovestONE S. The dementias. Lancet. (2002) 360:1759–66. doi: 10.1016/S0140-6736(02)11667-9

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Association As. (2021 Alzheimer's disease facts and figures. Alzheimers Dement. (2021) 17:327–406. doi: 10.1002/alz.12328

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Jia B, Liu Z, Min B, Wang Z, Zhou A, Li Y, et al. The effects of acupuncture at real or sham acupoints on the intrinsic brain activity in mild cognitive impairment patients. Evid Based Complement Alternat Med. (2015) 2015:529675. doi: 10.1155/2015/529675

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Chen S, Xu M, Li H, Liang J, Yin L, Liu X, et al. Acupuncture at the Taixi (KI3) acupoint activates cerebral neurons in elderly patients with mild cognitive impairment. Neural Regen Res. (2014) 9:1163–8. doi: 10.4103/1673-5374.135319

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Jia Y, Zhang X, Yu J, Han J, Yu T, Shi J, et al. Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial. BMC Complement Altern Med. (2017) 17:556. doi: 10.1186/s12906-017-2064-x

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Wang S, Yang H, Zhang J, Zhang B, Liu T, Gan L, et al. Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complement Altern Med. (2016) 16:361. doi: 10.1186/s12906-016-1337-0

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Feng X, Yang S, Liu J, Huang J, Peng J, Lin J, et al. Electroacupuncture ameliorates cognitive impairment through inhibition of NF-κB-mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured rats. Mol Med Rep. (2013) 7:1516–22. doi: 10.3892/mmr.2013.1392

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Yang Y, Hu S, Lin H, He J, Tang C. Electroacupuncture at GV24 and bilateral GB13 improves cognitive ability via influences the levels of Aβ, p-tau (s396) and p-tau (s404) in the hippocampus of Alzheimer's disease model rats. Neuroreport. (2020) 31:1072–83. doi: 10.1097/WNR.0000000000001518

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Zhu M. The Medical Classic of the Yellow Emperor. (2001). Beijing: Foreign Languages Press.

PubMed Abstract | Google Scholar

15. Wang T. Acupuncture for Brain: Treatment for Neurological and Psychologic Disorders. (2021). Cham: Springer Nature.

Google Scholar

16. Deng M, Wang X-F. Acupuncture for amnestic mild cognitive impairment: a meta-analysis of randomised controlled trials. Acupunct Med. (2016) 34:342–8. doi: 10.1136/acupmed-2015-010989

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Lu X, Hongcai S, Jiaying W, Jing H, Jun X. Assessing the quality of reports about randomized controlled trials of acupuncture treatment on mild cognitive impairment. PLoS ONE. (2011) 6:e16922. doi: 10.1371/journal.pONE.0016922

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. (2015) 105:1809–31. doi: 10.1007/s11192-015-1645-z

PubMed Abstract | CrossRef Full Text | Google Scholar

19. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. (2010) 84:523–38. doi: 10.1007/s11192-009-0146-3

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Chen C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inform Sci Technol. (2006) 57:724. doi: 10.1002/asi.20317

CrossRef Full Text | Google Scholar

21. Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. (2012) 12:593–608. doi: 10.1517/14712598.2012.674507

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. (2004) 101 Suppl 1:5303–10. doi: 10.1073/pnas.0307513100

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Chen CM, Leydesdorff L. Patterns of Connections and Movements in Dual-Map Overlays: A New Method of Publication Portfolio Analysis. J Assoc Inf Sci Technol. (2014) 65:334–51. doi: 10.1002/asi.22968

CrossRef Full Text | Google Scholar

24. PRICE DJdS. (1963). Little science, Big science. Columbia: Columbia University Press.

Google Scholar

25. Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun. (2020) 88:901–7. doi: 10.1016/j.bbi.2020.05.026

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Takeda T, Hosokawa M, Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence. J Am Geriatr Soc. (1991) 39:911–9. doi: 10.1111/j.1532-5415.1991.tb04460.x

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, et al. A new murine model of accelerated senescence. Mech Ageing Dev. (1981) 17:183–94. doi: 10.1016/0047-6374(81)90084-1

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Takeda T. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res. (2009) 34:639–59. doi: 10.1007/s11064-009-9922-y

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. (2004) 13:159–70. doi: 10.1093/hmg/ddh019

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. (2006) 26:10129–40. doi: 10.1523/JNEUROSCI.1202-06.2006

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Colom LV, Castaneda MT, Hernandez S, Perry G, Jaime S, Touhami A. Intrahippocampal amyloid-β (1-40) injections injure medial septal neurons in rats. Curr Alzheimer Res. (2011) 8:832–40. doi: 10.2174/156720511798192763

PubMed Abstract | CrossRef Full Text | Google Scholar

32. McLarnon JG, Ryu JK. Relevance of abeta1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain. Curr Alzheimer Res. (2008) 5:475–80. doi: 10.2174/156720508785908874

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Farkas E, Luiten PGM, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev. (2007) 54:162–80. doi: 10.1016/j.brainresrev.2007.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Cheng H, Yu J, Jiang Z, Zhang X, Liu C, Peng Y, et al. Acupuncture improves cognitive deficits and regulates the brain cell proliferation of SAMP8 mice. Neurosci Lett. (2008) 432:111–6. doi: 10.1016/j.neulet.2007.12.009

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Li G, Zhang X, Cheng H, Shang X, Xie H, Zhang X, et al. Acupuncture improves cognitive deficits and increases neuron density of the hippocampus in middle-aged SAMP8 mice. Acupunct Med. (2012) 30:339–45. doi: 10.1136/acupmed-2012-010180

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Zhao L, Zhou C, Li L, Liu J, Shi H, Kan B, et al. Acupuncture improves cerebral microenvironment in mice with Alzheimer's disease treated with hippocampal neural stem cells. Mol Neurobiol. (2017) 54:5120–30. doi: 10.1007/s12035-016-0054-5

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Zhou C-L, Zhao L, Shi H-Y, Liu J-W, Shi J-W, Kan B-H, et al. Combined acupuncture and treatment affects behavior and synaptophysin levels in the hippocampus of senescence-accelerated mouse prONE 8 after neural stem cell transplantation. Neural Regen Res. (2018) 13:541–8. doi: 10.4103/1673-5374.228760

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Chang S, Guo X, Li G, Zhang X, Li J, Jia Y, et al. Acupuncture promotes expression of Hsp84/86 and delays brain ageing in SAMP8 mice. Acupunct Med. (2019) 37:340–7. doi: 10.1136/acupmed-2017-011577

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Zhao L, Liu J-W, Kan B-H, Shi H-Y, Yang L-P, Liu X-Y. Acupuncture accelerates neural regeneration and synaptophysin production after neural stem cells transplantation in mice. World J Stem Cells. (2020) 12:1576–90. doi: 10.4252/wjsc.v12.i12.1576

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Li G, Zeng L, Cheng H, Han J, Zhang X, Xie H. Acupuncture administration improves cognitive functions and alleviates inflammation and nuclear damage by regulating phosphatidylinositol 3 kinase (PI3K)/phosphoinositol-dependent kinase 1 (PDK1)/novel protein kinase C (nPKC)/Rac 1 signaling pathway in senescence-accelerated PrONE 8 (SAM-P8) Mice. Med Sci Monit. (2019) 25:4082–93. doi: 10.12659/MSM.913858

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Dong W, Guo W, Zheng X, Wang F, Chen Y, Zhang W, et al. Electroacupuncture improves cognitive deficits associated with AMPK activation in SAMP8 mice. Metab Brain Dis. (2015) 30:777–84. doi: 10.1007/s11011-014-9641-1

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Dong W, Quo W, Wang F, Li C, Xie Y, Zheng X, et al. Electroacupuncture upregulates SIRT1-dependent PGC-1α expression in SAMP8 mice. Med Sci Monit. (2015) 21:3356–62. doi: 10.12659/MSM.894864

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Dong W-G, Wang F, Chen Y, Zheng X-H, Xie Y-C, Guo W-Q, et al. Electroacupuncture reduces Aβ production and BACE1 expression in SAMP8 mice. Front Aging Neurosci. (2015) 7:148. doi: 10.3389/fnagi.2015.00148

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Ding N, Jiang J, Xu A, Tang Y, Li Z. Manual acupuncture regulates behavior and cerebral blood flow in the SAMP8 mouse model of Alzheimer's disease. Front Neurosci. (2019) 13:37. doi: 10.3389/fnins.2019.00037

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Jiang J, Liu H, Wang Z, Tian H, Wang S, Yang J, et al. Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model. PLoS ONE. (2021) 16:e0259530. doi: 10.1371/journal.pONE.0259530

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Liang P-Z, Li L, Zhang Y-N, Shen Y, Zhang L-L, Zhou J, et al. Electroacupuncture improves clearance of amyloid- through the glymphatic system in the SAMP8 mouse model of Alzheimer's disease. Neural Plast. (2021) 2021:9960304. doi: 10.1155/2021/9960304

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Jiang J, Liu G, Shi S, Li Y, Li Z. Effects of manual acupuncture combined with dONEpezil in a mouse model of Alzheimer's disease. Acupunct Med. (2019) 37:64–71. doi: 10.1136/acupmed-2016-011310

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Dong W, Yang W, Li F, Guo W, Qian C, Wang F, et al. Electroacupuncture improves synaptic function in SAMP8 mice probably via inhibition of the AMPK/eEF2K/eEF2 signaling pathway. Evid Based Complement Alternat Med. (2019) 2019:8260815. doi: 10.1155/2019/8260815

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Hou Z, Qiu R, Wei Q, Liu Y, Wang M, Mei T, et al. Electroacupuncture improves cognitive function in senescence-accelerated P8 (SAMP8) mice via the NLRP3/caspase-1 pathway. Neural Plast. (2020) 2020:8853720. doi: 10.1155/2020/8853720

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Wang X, Li Z, Li C, Wang Y, Yu S, Ren L. Electroacupuncture with Bushen Jiannao improves cognitive deficits in senescence-accelerated mouse prONE 8 mice by inhibiting neuroinflammation. J Tradit Chin Med. (2020) 40:812–9. doi: 10.19852/j.cnki.jtcm.2020.05.011

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Li X, Guo F, Zhang Q, Huo T, Liu L, Wei H, et al. Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice. BMC Complement Altern Med. (2014) 14:37. doi: 10.1186/1472-6882-14-37

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Lin R, Li L, Zhang Y, Huang S, Chen S, Shi J, et al. Electroacupuncture ameliorate learning and memory by improving N-acetylaspartate and glutamate metabolism in APP/PS1 mice. Biol Res. (2018) 51:21. doi: 10.1186/s40659-018-0166-7

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Liu W, Zhuo P, Li L, Jin H, Lin B, Zhang Y, et al. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture. Free Radic Biol Med. (2017) 112:174–90. doi: 10.1016/j.freeradbiomed.2017.07.024

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Wang F, Zhong H, Li X, Peng Y, Kinden R, Liang W, et al. Electroacupuncture attenuates reference memory impairment associated with astrocytic NDRG2 suppression in APP/PS1 transgenic mice. Mol Neurobiol. (2014) 50:305–13. doi: 10.1007/s12035-013-8609-1

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Lin R, Chen J, Li X, Mao J, Wu Y, Zhuo P, et al. Electroacupuncture at the Baihui acupoint alleviates cognitive impairment and exerts neuroprotective effects by modulating the expression and processing of brain-derived neurotrophic factor in APP/PS1 transgenic mice. Mol Med Rep. (2016) 13:1611–7. doi: 10.3892/mmr.2015.4751

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Cao J, Tang Y, Li Y, Gao K, Shi X, Li Z. Behavioral changes and hippocampus glucose metabolism in APP/PS1 transgenic mice via electro-acupuncture at governor vessel acupoints. Front Aging Neurosci. (2017) 9:5. doi: 10.3389/fnagi.2017.00005

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Xu A, Tang Y, Zeng Q, Wang X, Tian H, Zhou Y, et al. Electroacupuncture enhances cognition by promoting brain glucose metabolism and inhibiting inflammation in the APP/PS1 mouse model of Alzheimer's disease: a pilot study. J Alzheimers Dis. (2020) 77:387–400. doi: 10.3233/JAD-200242

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Tang Y, Shao S, Guo Y, Zhou Y, Cao J, Xu A, et al. Electroacupuncture mitigates hippocampal cognitive impairments by reducing BACE1 deposition and activating PKA in APP/PS1 double transgenic mice. Neural Plast. (2019) 2019:2823679. doi: 10.1155/2019/2823679

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Tang Y, Xu A, Shao S, Zhou Y, Xiong B, Li Z. Electroacupuncture ameliorates cognitive impairment by inhibiting the JNK signaling pathway in a mouse model of Alzheimer's disease. Front Aging Neurosci. (2020) 12:23. doi: 10.3389/fnagi.2020.00023

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Xu A, Zeng Q, Tang Y, Wang X, Yuan X, Zhou Y, et al. Electroacupuncture protects cognition by regulating tau phosphorylation and glucose metabolism via the AKT/GSK3β signaling pathway in Alzheimer's disease model mice. Front Neurosci. (2020) 14:585476. doi: 10.3389/fnins.2020.585476

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Yang Q, Zhu S, Xu J, Tang C, Wu K, Wu Y, et al. Effect of the electro-acupuncture on senile plaques and its formation in APP/PS1 double transgenic mice. Genes Dis. (2019) 6:282–9. doi: 10.1016/j.gendis.2018.06.002

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Li J, Zhang B, Jia W, Yang M, Zhang Y, Zhang J, et al. Activation of adenosine monophosphate-activated protein kinase drives the aerobic glycolysis in hippocampus for delaying cognitive decline following electroacupuncture treatment in APP/PS1 mice. Front Cell Neurosci. (2021) 15:774569. doi: 10.3389/fncel.2021.774569

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Cai M, Yang EJ. Effect of Combined Electroacupuncture and selegiline treatment in Alzheimer's disease: an animal model. Front Pharmacol. (2020) 11:606480. doi: 10.3389/fphar.2020.606480

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Cai M, Lee J-H, Yang EJ. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model. J Neuroinflammation. (2019) 16:264. doi: 10.1186/s12974-019-1665-3

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Zheng X, Lin W, Jiang Y, Lu K, Wei W, Huo Q, et al. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB). Autophagy. (2021) 17:3833–47. doi: 10.1080/15548627.2021.1886720

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Li L, Li J, Dai Y, Yang M, Liang S, Wang Z, et al. Electro-acupuncture improve the early pattern separation in Alzheimer's disease mice basal forebrain-hippocampus cholinergic neural circuit. Front Aging Neurosci. (2021) 13:770948. doi: 10.3389/fnagi.2021.770948

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Zhang M, Xv G-H, Wang W-X, Meng D-J, Ji Y. Electroacupuncture improves cognitive deficits and activates PPAR-γ in a rat model of Alzheimer's disease. Acupunct Med. (2017) 35:44–51. doi: 10.1136/acupmed-2015-010972

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Guo H-D, Tian J-X, Zhu J, Li L, Sun K, Shao S-J, et al. Electroacupuncture suppressed neuronal apoptosis and improved cognitive impairment in the AD model rats possibly via downregulation of notch signaling pathway. Evid Based Complement Alternat Med. (2015) 2015:393569. doi: 10.1155/2015/393569

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Yu C-C, Wang Y, Shen F, Kong L-H, Wang Y-W, Zhou H, et al. High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1-42-induced Alzheimer's disease. Neural Regen Res. (2018) 13:1833–41. doi: 10.4103/1673-5374.238620

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Wang Y, Zheng A, Yang H, Wang Q, Ren B, Guo T, et al. “Olfactory three-needle” acupuncture enhances synaptic function in Aβ-induced Alzheimer's disease via activating PI3K/AKT/GSK-3β signaling pathway. J Integr Neurosci. (2021) 20:55–65. doi: 10.31083/j.jin.2021.01.224

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Wang X-R, Shi G-X, Yang J-W, Yan C-Q, Lin L-T, Du S-Q, et al. Acupuncture ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia through Nrf2-mediated antioxidant response. Free Radic Biol Med. (2015) 89:1077–84. doi: 10.1016/j.freeradbiomed.2015.10.426

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Zhu W, Wang X-R, Du S-Q, Yan C-Q, Yang N-N, Lin L-L, et al. Anti-oxidative and Anti-apoptotic Effects of Acupuncture: Role of Thioredoxin-1 in the Hippocampus of Vascular Dementia Rats. Neuroscience. (2018) 379:281–91. doi: 10.1016/j.neuroscience.2018.03.029

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Du S-Q, Wang X-R, Zhu W, Ye Y, Yang J-W, Ma S-M, et al. Acupuncture inhibits TXNIP-associated oxidative stress and inflammation to attenuate cognitive impairment in vascular dementia rats. CNS Neurosci Ther. (2018) 24:39–46. doi: 10.1111/cns.12773

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y, et al. nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. (2020) 33:e100213. doi: 10.1136/gpsych-2020-100213

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Ye Y, Li H, Yang J-W, Wang X-R, Shi G-X, Yan C-Q, et al. Acupuncture attenuated vascular dementia-induced hippocampal long-term potentiation impairments via activation of D1/D5 receptors. Stroke. (2017) 48:1044–51. doi: 10.1161/STROKEAHA.116.014696

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Li H, Liu Y, Lin L-T, Wang X-R, Du S-Q, Yan C-Q, et al. Acupuncture reversed hippocampal mitochondrial dysfunction in vascular dementia rats. Neurochem Int. (2016) 92:35–42. doi: 10.1016/j.neuint.2015.12.001

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. (2020) 7:e14. doi: 10.1016/S2215-0366(20)30047-X

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Yang J-W, Wang X-R, Zhang M, Xiao L-Y, Zhu W, Ji C-S, et al. Acupuncture as a multifunctional neuroprotective therapy ameliorates cognitive impairment in a rat model of vascular dementia: a quantitative iTRAQ proteomics study. CNS Neurosci Ther. (2018) 24:1264–74. doi: 10.1111/cns.13063

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Zhu Y, Zeng Y, Wang X, Ye X. Effect of electroacupuncture on the expression of mTOR and eIF4E in hippocampus of rats with vascular dementia. Neurol Sci. (2013) 34:1093–7. doi: 10.1007/s10072-012-1209-4

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Zhu Y, Wu Q, Lin L. Effects of electro-acupuncture on Noxa and caspase-3 expression in hippocampal CA1 region of a vascular dementia rat model. Neural Regener Res. (2008) 3:826–31.

Google Scholar

81. Zhu Y, Zeng Y. Electroacupuncture protected pyramidal cells in hippocampal CA1 region of vascular dementia rats by inhibiting the expression of p53 and Noxa. CNS Neurosci Ther. (2011) 17:599–604. doi: 10.1111/j.1755-5949.2010.00192.x

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Wei D, Jia X, Yin X, Jiang W. Effects of electroacupuncture versus nimodipine on long-term potentiation and synaptophysin expression in a rat model of vascular dementia. Neural Regener Res. (2011) 6:2357–61. doi: 10.3969/j.issn.1673-5374.2011.30.007

CrossRef Full Text | Google Scholar

83. Bu Y, Li W-S, Lin J, Wei Y-W, Sun Q-Y, Zhu S-J, et al. Electroacupuncture attenuates immune-inflammatory response in hippocampus of rats with vascular dementia by inhibiting TLR4/MyD88 signaling pathway. Chin J Integr Med. (2022) 28:153–61. doi: 10.1007/s11655-021-3350-5

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Zhu Y, Wang X, Ye X, Gao C, Wang W. Effects of electroacupuncture on the expression of p70 ribosomal protein S6 kinase and ribosomal protein S6 in the hippocampus of rats with vascular dementia. Neural Regener Res. (2012) 7:207–11. doi: 10.3969/j.issn.1673-5374.2012.03.009

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing Aβ generation and amyloid plaque pathogenesis. J Neurosci. (2015) 35:12137–51. doi: 10.1523/JNEUROSCI.0705-15.2015

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Feng Y, Bai L, Ren Y, Chen S, Wang H, Zhang W, et al. FMRI connectivity analysis of acupuncture effects on the whole brain network in mild cognitive impairment patients. Magn Reson Imaging. (2012) 30:672–82. doi: 10.1016/j.mri.2012.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Zheng W, Su Z, Liu X, Zhang H, Han Y, Song H, et al. Modulation of functional activity and connectivity by acupuncture in patients with Alzheimer disease as measured by resting-state fMRI. PLoS ONE. (2018) 13:e0196933. doi: 10.1371/journal.pONE.0196933

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Chen S, Bai L, Xu M, Wang F, Yin L, Peng X, et al. Multivariate granger causality analysis of acupuncture effects in mild cognitive impairment patients: an FMRI study. Evid Based Complement Alternat Med. (2013) 2013:127271. doi: 10.1155/2013/127271

PubMed Abstract | CrossRef Full Text | Google Scholar

89. Yan W-T, Yang Y-D, Hu X-M, Ning W-Y, Liao L-S, Lu S, et al. Do pyroptosis, apoptosis, and necroptosis (PANoptosis) exist in cerebral ischemia? Evidence from cell and rodent studies. Neural Regen Res. (2022) 17:1761–8. doi: 10.4103/1673-5374.331539

PubMed Abstract | CrossRef Full Text | Google Scholar

90. Chen Y, Li Y, Guo L, Hong J, Zhao W, Hu X, et al. Bibliometric analysis of the inflammasome and pyroptosis in brain. Front Pharmacol. (2020) 11:626502. doi: 10.3389/fphar.2020.626502

PubMed Abstract | CrossRef Full Text | Google Scholar

91. Yan W-T, Lu S, Yang Y-D, Ning W-Y, Cai Y, Hu X-M, et al. Research trends, hot spots and prospects for necroptosis in the field of neuroscience. Neural Regen Res. (2021) 16:1628–37. doi: 10.4103/1673-5374.303032

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: acupuncture therapy, cognitive impairment, VOSviewer, CiteSpace, scientometric analysis

Citation: Zhou R, Xiao L, Xiao W, Yi Y, Wen H and Wang H (2022) Bibliometric review of 1992–2022 publications on acupuncture for cognitive impairment. Front. Neurol. 13:1006830. doi: 10.3389/fneur.2022.1006830

Received: 29 July 2022; Accepted: 30 August 2022;
Published: 26 September 2022.

Edited by:

Lingyong Xiao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Reviewed by:

Timothy Daly, Sorbonne Universités, France
Kun Xiong, Central South University, China
Lv Xie, Shanghai Jiao Tong University, China
Ruoyu Yang, Shanghai University of Medicine and Health Sciences, China

Copyright © 2022 Zhou, Xiao, Xiao, Yi, Wen and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lu Xiao, xiaolu9511@163.com

These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.